Severe ARIA after Lecanemab Treatment
Author Information
Author(s): A. Yamazaki, T. Sekine, S. Takahashi, K. Sohara, M. Sakamaki, T. Nagao, K. Kimura, M. Mishina
Primary Institution: Nippon Medical School
Hypothesis
Can lecanemab treatment lead to severe amyloid-related imaging abnormalities (ARIA) with multiple infarctions and extensive microbleeds?
Conclusion
The case highlights the occurrence of severe ARIA with numerous microbleeds and cerebral microinfarctions following lecanemab treatment.
Supporting Evidence
- The patient developed numerous microbleeds and cerebral microinfarctions after lecanemab treatment.
- Previous studies reported limited microbleeds in severe ARIA cases, making this case unique.
- Despite numerous microbleeds, there was no evidence of superficial siderosis.
- The patient exhibited severe changes sufficient to cause a midline shift, necessitating intensive care.
Takeaway
One patient had serious side effects after taking a new Alzheimer's drug, showing many small brain bleeds and strokes.
Methodology
The patient was treated with lecanemab and monitored through MRI and cognitive assessments.
Limitations
The APOE genotype was not assessed due to lack of genetic testing coverage.
Participant Demographics
57-year-old married woman with 16 years of education.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website